Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1

Conditions

Polycystic Ovary Syndrome 2Weight Loss 1Prediabetic State 1Obesity, Abdominal 1Glucose Intolerance 1Cardiovascular Diseases 1

Interventions

Cyclophosphamide 909Carboplatin 787pembrolizumab 744Paclitaxel 742Cisplatin 709Bevacizumab 706Gemcitabine 619Docetaxel 579Rituximab 548Radiotherapy 541Dexamethasone 511Nivolumab 488Doxorubicin 444Fluorouracil 392Capecitabine 376Etoposide 358Pemetrexed 337Cytarabine 335Oxaliplatin 333Lenalidomide 328Prednisone 326fludarabine phosphate 316Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 276

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Has results × Liraglutide × Clear all
NCT03480022 2021-06-07

SAXAPCOS

Woman's

Phase 3 Completed
88 enrolled 35 charts
Other

Polycystic Ovary Syndrome, Prediabetic State, Weight Loss, Glucose Intolerance, Obesity, Abdominal

NCT02073929 2019-02-28

LIPT

Herlev Hospital

Phase 4 Completed
72 enrolled 18 charts

Cardiovascular Diseases, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡